Zymeworks (ZYME) Total Current Liabilities (2021 - 2026)

Zymeworks' (ZYME) quarterly Total Current Liabilities came in at $35.6 million in Q1 2026, down 45.24% year-on-year from $65.1 million in Q1 2025, and down 15.76% quarter-over-quarter from $42.3 million in Q4 2025.

Zymeworks (ZYME) Total Current Liabilities (2021 - 2026) Analysis & Trends

Zymeworks has disclosed Total Current Liabilities across 6 years of filings, most recently posting $35.6 million for Q1 2026.

  • Total Current Liabilities for Q1 2026 came in at $35.6 million, down 45.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.6 million (down 45.24% YoY), and the FY2025 annual result was $42.3 million, down 52.07% from the prior year.
  • Total Current Liabilities came in at $35.6 million for Q1 2026 at Zymeworks, down from $42.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $95.6 million in Q4 2022 to a low of $35.6 million in Q1 2026.
  • The 5-year median for Total Current Liabilities is $57.7 million (2022), against an average of $63.3 million.
  • Across the five-year window, Total Current Liabilities surged 58.34% in 2024 and tumbled 52.07% in 2025, its largest moves.
  • Zymeworks' Total Current Liabilities stood at $95.6 million in 2022, then slumped by 41.69% to $55.8 million in 2023, then surged by 58.34% to $88.3 million in 2024, then slumped by 52.07% to $42.3 million in 2025, then dropped by 15.76% to $35.6 million in 2026.
  • The last three Total Current Liabilities figures came in at $35.6 million (Q1 2026), $42.3 million (Q4 2025), and $42.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 Zymeworks 1.73 Bn 1.36 Bn - 35.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 35.65 Mn
Dec 31, 2025 42.32 Mn
Sep 30, 2025 42.04 Mn
Jun 30, 2025 38.50 Mn
Mar 31, 2025 65.10 Mn
Dec 31, 2024 88.29 Mn
Sep 30, 2024 83.91 Mn
Jun 30, 2024 54.71 Mn
Mar 31, 2024 56.89 Mn
Dec 31, 2023 55.76 Mn
Sep 30, 2023 72.85 Mn
Jun 30, 2023 93.55 Mn
Mar 31, 2023 67.32 Mn
Dec 31, 2022 95.63 Mn
Sep 30, 2022 57.71 Mn
Dec 31, 2021 71.85 Mn